We are live on
!
Find out more
GP
Grow Partners Portfolio holdings
AUM
$4.81M
1-Year Est. Return
7.86%
This Fund
S&P 500
This Quarter
Est. Return
+11.58%
1 Year Est. Return
+7.86%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$164M
AUM Growth
–
Cap. Flow
+$207M
Cap. Flow
% of AUM
126.37%
Top 10 Holdings %
Top 10 Hldgs %
57.76%
Holding
34
New
34
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NeoGenomics
NEO
|
+$13.2M |
| 2 |
IMPV
Imperva, Inc.
IMPV
|
+$11.4M |
| 3 |
Ligand Pharmaceuticals
LGND
|
+$10.4M |
| 4 |
EOX
EMERALD OIL INC (MT)
EOX
|
+$10.2M |
| 5 |
NVDQ
Novadaq Technologies Inc.
NVDQ
|
+$9.23M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 34.79% |
| 2 | Technology | 34.06% |
| 3 | Industrials | 9.84% |
| 4 | Energy | 7.78% |
| 5 | Financials | 1.83% |
Similar funds
GH
STIA
RCM
BPCM
KC
AIM
NA
LSVI
Grow Partners's Q4 2013 Portfolio in Review
Q4 2013 is the first quarter with a 13F filing on record for Grow Partners, which disclosed 34 positions worth $164M. Its ten largest holdings account for 58% of the portfolio.
Its largest position is NeoGenomics: 3,790,000 shares worth $13.7M.
By sector, the portfolio is most concentrated in Healthcare at 35% of assets, followed by Technology and Industrials.
- Grow Partners's largest Q4 2013 buy was NeoGenomics: 3,790,000 shares worth $13.7M.
- Grow Partners's ten largest holdings make up 58% of its $164M portfolio in Q4 2013.
- Grow Partners disclosed 34 positions in Q4 2013, its first 13F filing on record.
Based on Grow Partners's 13F filing for Q4 2013, filed 18 Feb 2014.